Matches in Nanopublications for { ?s ?p "[These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion description "[These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion description "[These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.